Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

  • This share is currently suspended. It was suspended at a price of 37.50
  • There is currently no data for CAT

Conversion of Securities

10 Aug 2012 07:00

RNS Number : 7234J
CATCo Reinsurance Opps Fund Ltd
10 August 2012
 



 

 

CATCo Reinsurance Opportunities Fund Ltd. (the "Company")

 

C Share Conversion Ratio and Admission of New Ordinary Shares

 

To: SFM, London Stock Exchange and the Bermuda Stock Exchange

Date: 10 August 2012

 

 

Further to its announcement of 8 August 2012, the Board of the Company is pleased to announce the following information in relation to the conversion of its C Shares.

Conversion Ratio for C Shares

The Net Asset Values as at the Calculation Time (being 8 August 2012) for an Ordinary Share and a C Share were $0.98 and $1.1329 respectively. Accordingly, the Conversion Ratio for conversion of the C Shares, as calculated in accordance with the Company's prospectus dated 18 May 2011 (the "Prospectus"), is 1.15602825 Ordinary Shares for every one C Share held.

On the basis of the Conversion Ratio, a holder of 1,000 C Shares will receive 1,156 new Ordinary Shares upon Conversion.

Entitlements will be rounded down to the nearest whole share.

Ordinary Shares arising on Conversion will rank pari passu with, and will have the same rights as, the Ordinary Shares of the Company already in issue.

Further details of the Conversion and rights attaching to the C Shares are set out in the Prospectus.

Admission to trading on the Specialist Fund Market of the London Stock Exchange

On the basis of the Conversion Ratio, application has been made to the London Stock Exchange for 282,207,337 Ordinary Shares to be admitted to trading on the Specialist Fund Market. It is anticipated that such admission will become effective, and that dealings in the Ordinary Shares will commence, on 13 August 2012. As a result of this share issue, the Company has in issue 369,849,337 Ordinary Shares.

Cancellation of C Shares

The C Shares will be permanently removed from trading on the London Stock Exchange with effect from the opening of trading at 8.00 a.m. on 13 August 2012.

Expected timetable

Record date for Conversion and C Share register closes

Close of business on 10 August 2012

 

Dealings in new Ordinary Shares commence

13 August 2012

 

Crediting of CREST accounts with new Ordinary Shares

13 August 2012

 

Share certificates in respect of new Ordinary Shares despatched

Week commencing 13 August 2012

 

Defined words and terms used in this announcement shall have the same meaning as ascribed to them in the Prospectus. 

 

-Ends-

 

For further information, please contact:

 

Jason Bibb, Director/Michael Toyer, Head of Investment Operations

CATCo Investment Management Ltd

Telephone: +1 441 531 2227

Email: jason.bibb@catcoim.com 

Email: Michael.toyer@catcoim.com

 

David Benda / Hugh Jonathan

Numis Securities Limited

Telephone: +44 (0)20 7260 1000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CONLLFVETDIAIIF
Date   Source Headline
29th Mar 201111:40 amRNSIssue of Equity
29th Mar 201111:36 amRNSDirector/PDMR Shareholding
7th Mar 20111:49 pmRNSNet Asset Value(s)
7th Feb 20118:30 amRNSPortfolio Update
7th Feb 20118:11 amRNSNet Asset Value(s)
14th Jan 20117:00 amRNSPortfolio Update
7th Jan 20113:33 pmRNSHolding(s) in Company
23rd Dec 201011:00 amRNSHolding(s) in Company
20th Dec 20107:00 amRNSResult of Placing and Admission to SFM
13th Jul 20064:12 pmRNSHolding(s) in Company
10th Jul 20063:20 pmRNSHolding(s) in Company
7th Jul 20062:51 pmRNSOffer for Cambridge Antibody
3rd Jul 20064:56 pmRNSDirectorate Change
30th Jun 20064:12 pmRNSHolding(s) in Company
30th Jun 20064:06 pmRNSDelisting
30th Jun 200610:27 amRNSAdditional Listing
30th Jun 20067:02 amRNSOffer for Cambridge Antibody
27th Jun 20062:26 pmRNSHolding(s) in Company
27th Jun 200612:34 pmRNSHolding(s) in Company
23rd Jun 20062:25 pmRNSAppointment of Directors
22nd Jun 20063:07 pmRNSRule 8.3- CAT
22nd Jun 200611:31 amRNSCAT Limited appoints new CE
22nd Jun 200611:11 amRNSEPT Disclosure
22nd Jun 200611:09 amRNSEPT Disclosure
22nd Jun 20067:02 amRNSOffer for Cambridge Antibody
21st Jun 20065:11 pmRNSRule 8.1- C.A.T.
21st Jun 200611:30 amRNSEPT Disclosure
21st Jun 200610:20 amRNSEPT Disclosure
20th Jun 200610:36 amRNSEPT Disclosure
20th Jun 200610:36 amRNSEPT Disclosure
19th Jun 20063:25 pmRNSRule 8.3 - Cambridge Antibody
19th Jun 20061:07 pmRNSRule 8.3- (CAT)
19th Jun 200611:30 amRNSEPT Disclosure
19th Jun 200611:23 amRNSEPT Disclosure
19th Jun 200610:33 amRNSEPT Disclosure
16th Jun 200611:45 amRNSEPT Disclosure
16th Jun 200611:24 amRNSEPT Disclosure
16th Jun 200611:08 amRNSEPT Disclosure
15th Jun 20065:01 pmRNSEPT Disclosure
15th Jun 20062:48 pmRNSRule 8.3- (CAT)
15th Jun 20062:17 pmRNSRule 2.10 Announcement
15th Jun 200612:45 pmRNSEPT Disclosure
15th Jun 200611:36 amRNSEPT Disclosure
14th Jun 20063:38 pmRNSRule 8.3- Cambridge Antibody
14th Jun 20063:05 pmRNSRule 8.3- Cambridge Antibody
14th Jun 20061:43 pmRNSRule 8.3- (CAT)
14th Jun 200611:36 amRNSEPT Disclosure
14th Jun 200611:15 amRNSEPT Disclosure
14th Jun 200610:59 amRNSEPT Disclosure
14th Jun 200610:23 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.